{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-006237","form_type":"8-K","ticker":"SNGX","cik":"0000812796","company_name":"SOLIGENIX, INC.","filed_at":"2023-04-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.334554+00:00","generated_at":"2026-06-17T00:04:45.438988+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Soligenix amends loan with Pontifax; repays $5M; reduces minimum cash covenant to $1.5M","bullets":["Repaid $5M of $8M loan principal, leaving $3M outstanding; prepayment premium eliminated.","Minimum cash covenant reduced from $4.5M to $1.5M; falls to $0 if $10M raised by Dec 31, 2023.","Conversion price set at 90% of prior day's close for first 588,599 shares; $1.70 thereafter.","FDA refusal to file HyBryte NDA triggered an Event of Default, waived until Dec 31, 2023 if $5.6M raised.","Interest-only period extended to Dec 31, 2023 if $5.6M raised; to June 30, 2024 if $10M raised."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-006237","json":"https://secwatch.observer/filing/0001558370-23-006237.json","markdown":"https://secwatch.observer/filing/0001558370-23-006237.md","text":"https://secwatch.observer/filing/0001558370-23-006237.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/812796/000155837023006237/0001558370-23-006237-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/812796/000155837023006237/sngx-20230419x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T00:04:45.438988+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}